Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

NCT03313544 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Non-small Cell
Lung Cancer

Interventions

DRUG: Nivolumab
DEVICE: MRI
BIOLOGICAL: BLOOD SAMPLES
DEVICE: trans-thoracic echocardiography

Sponsor

Assistance Publique Hopitaux De Marseille